Lipoprotein(a): Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 23: | Line 23: | ||
[[Lipoprotein(a) medical therapy|Medical Therapy]] | [[Lipoprotein(a) primary prevention|Primary Prevention]] | [[Lipoprotein(a) secondary prevention|Secondary Prevention]] | [[Lipoprotein(a) landmark trials|Landmark Trials]] | [[Lipoprotein(a) future or investigational therapies|Future or Investigational Therapies]] | [[Lipoprotein(a) medical therapy|Medical Therapy]] | [[Lipoprotein(a) primary prevention|Primary Prevention]] | [[Lipoprotein(a) secondary prevention|Secondary Prevention]] | [[Lipoprotein(a) landmark trials|Landmark Trials]] | [[Lipoprotein(a) future or investigational therapies|Future or Investigational Therapies]] | ||
{{Lipopedia}} | |||
{{Lipoproteins}} | {{Lipoproteins}} | ||
Revision as of 21:55, 12 September 2013
Template:Lipoprotein(a) Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Biochemistry
Physiology
Clinical Correlation
High lipoprotein(a)
Epidemiology and Demographics | Pathophysiology | Causes | Diseases | Prognosis and Complications
Low lipoprotein(a)
Epidemiology and Demographics | Pathophysiology | Causes | Diseases | Prognosis and Complications
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Landmark Trials | Future or Investigational Therapies